Collapsing glomerulopathy

Journal of the American Society of Nephrology

Volumn 17, Issue 10, 2006, Pages 2854-2863

  Albaqumi, Mamdouh ^a   Soos, Timothy J ^a   Barisoni, Laura ^a   Nelson, Peter J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; GENETIC SUSCEPTIBILITY; GLOMERULOPATHY; HISTOPATHOLOGY; HUMAN; KIDNEY FAILURE; KIDNEY INJURY; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; RACE DIFFERENCE; REVIEW;

EID: 33749256664     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006030225     Document Type: Review

References (132)

1. Valeri A, Barisoni L, Appel GB, Seigle R, D'Agati V: Idiopathic collapsing focal segmental glomerulosclerosis: A clinicopathologic study. Kidney Int 50: 1734-1746, 1996
2. Velosa JA, Donadio JV Jr, Holley KE: Focal sclerosing glomerulonephropathy: A clinicopathologic study. Mayo Clin Proc 50: 121-133, 1975
3. Grishman E, Churg J: Focal glomerular sclerosis in nephrotic patients: An electron microscopic study of glomerular podocytes. Kidney Int 7: 111-122, 1975
4. Beaufils H, Alphonse JC, Guedon J, Legrain M: Focal glomerulosclerosis: Natural history and treatment. A report of 70 cases. Nephron 21: 75-85, 1978
5. Brown CB, Cameron JS, Turner DR, Chantler C, Ogg CS, Williams DG, Bewick M: Focal segmental glomerulosclerosis with rapid decline in renal function ("malignant FSGS"). Clin Nephrol 10: 51-61, 1978
6. Ray PE, Xu L, Rakusan T, Liu XH: A 20-year history of childhood HIV-associated nephropathy. Pediatr Nephrol 19: 1075-1092, 2004
7. Ross MJ, Klotman PE: HIV-associated nephropathy. AIDS 18: 1089-1099, 2004
8. Weiner NJ, Goodman JW, Kimmel PL: The HIV-associated renal diseases: Current insight into pathogenesis and treatment. Kidney Int 63: 1618-1631, 2003
9. Rao TK, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, Friedman EA: Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 310: 669-673, 1984
10. Pardo V, Aldana M, Colton RM, Fischl MA, Jaffe D, Moskowitz L, Hensley GT, Bourgoignie JJ: Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med 101: 429-434, 1984
11. Schwartz MM, Lewis EJ: Focal segmental glomerular sclerosis: The cellular lesion. Kidney Int 28: 968-974, 1985
12. Weiss MA, Daquioag E, Margolin EG, Pollak VE: Nephrotic syndrome, progressive irreversible renal failure, and glomerular "collapse": A new clinicopathologic entity? Am J Kidney Dis 7: 20-28, 1986
13. Laurinavicius A, Hurwitz S, Rennke HG: Collapsing glomerulopathy in HIV and non-HIV patients: A clinicopathological and follow-up study. Kidney Int 56: 2203-2213, 1999
14. Schwartz MM, Evans J, Bain R, Korbet SM: Focal segmental glomerulosclerosis: Prognostic implications of the cellular lesion. J Am Soc Nephrol 10: 1900-1907, 1999
15. Grcevska L, Polenakovik M: Collapsing glomerulopathy: Clinical characteristics and follow-up. Am J Kidney Dis 33: 652-657, 1999
16. Detwiler RK, Falk RJ, Hogan SL, Jennette JC: Collapsing glomerulopathy: A clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45: 1416-1424, 1994
17. Haas M, Spargo BH, Coventry S: Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: A 20-year renal biopsy study. Am J Kidney Dis 26: 740-750, 1995
18. Thomas DB, Franceschini N, Hogan SL, Ten Holder S, Jennette CE, Falk RJ, Jennette JC: Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int 69: 920-926, 2006
19. Laurinavicius A, Rennke HG: Collapsing glomerulopathy: A new pattern of renal injury. Semin Diagn Pathol 19: 106-115, 2002
20. D'Agati V: Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol 23: 117-134, 2003
21. D'Agati VD, Fogo AB, Bruijn JA, Jennette JC: Pathologic classification of focal segmental glomerulosclerosis: A working proposal. Am J Kidney Dis 43: 368-382, 2004
22. Ross MJ, Bruggeman L, Wilson PD, Klotman PE: Microcyst formation and HIV-1 gene expression occur in multiple nephron segments in HIV-associated nephropathy. J Am Soc Nephrol 12: 2645-2651, 2001
23. Bodi I, Abraham AA, Kimmel PL: Macrophages in human immunodeficiency virus-associated kidney diseases. Am J Kidney Dis 24: 762-767, 1994
24. Bariety J, Nochy D, Mandet C, Jacquot C, Glotz D, Meyrier A: Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy. Kidney Int 53: 918-925, 1998
25. Bariety J, Bruneval P, Hill G, Irinopoulou T, Mandet C, Meyrier A: Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation. J Am Soc Nephrol 12: 261-274, 2001
26. Barisoni L, Kriz W, Mundel P, D'Agati V: The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10: 51-61, 1999
27. Barisoni L, Mokrzycki M, Sablay L, Nagata M, Yamase H, Mundel P: Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies. Kidney Int 58: 137-143, 2000
28. Shankland SJ, Eitner F, Hudkins KL, Goodpaster T, D'Agati V, Alpers CE: Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: Role in podocyte proliferation and maturation. Kidney Int 58: 674-683, 2000
29. Nagata M, Hattori M, Hamano Y, Ito K, Saitoh K, Watanabe T: Origin and phenotypic features of hyperplastic epithelial cells in collapsing glomerulopathy. Am J Kidney Dis 32: 962-969, 1998
30. Nagata M, Horita S, Shu Y, Shibata S, Hattori M, Ito K, Watanabe T: Phenotypic characteristics and cyclin-dependent kinase inhibitors repression in hyperplastic epithelial pathology in idiopathic focal segmental glomerulosclerosis. Lab Invest 80: 869-880, 2000
31. Yang Y, Gubler MC, Beaufils H: Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy. Nephron 91: 416-423, 2002
32. Barisoni L, Kopp JB: Modulation of podocyte phenotype in collapsing glomerulopathies. Microsc Res Tech 57: 254-262, 2002
33. Petermann A, Hiromura K, Pippin J, Blonski M, Couser WG, Kopp J, Mundel P, Shankland SJ: Differential expression of d-type cyclins in podocytes in vitro and in vivo. Am J Pathol 164: 1417-1424, 2004
34. Srivastava T, Garola RE, Singh HK: Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children. Kidney Int 70: 529-535, 2006
35. Dijkman H, Smeets B, van der Laak J, Steenbergen E, Wetzels J: The parietal epithelial cell is crucially involved in human idiopathic segmental glomerulosclerosis. Kidney Int 68: 1562-1572, 2005
36. Dijkman HB, Weening JJ, Smeets B, Verrijp KC, van Kuppevelt TH, Assmann KK, Steenbergen EJ, Wetzels J: Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. Kidney Int 70: 338-344, 2006
37. Presne C, Cordonnier C, Makdassi R, Pruna A, Fournier A: Collapsing glomerulopathy and cytomegalovirus, what are the links? Presse Med 29: 1815-1817, 2000
38. Tomlinson L, Boriskin Y, McPhee I, Holwill S, Rice P: Acute cytomegalovirus infection complicated by collapsing glomerulopathy. Nephrol Dial Transplant 18: 187-189, 2003
39. Moudgil A, Nast CC, Bagga A, Wei L, Nurmamet A, Cohen AH, Jordan SC, Toyoda M: Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int 59: 2126-2133, 2001
40. Moudgil A, Shidban H, Nast CC, Bagga A, Aswad S, Graham SL, Mendez R, Jordan SC: Parvovirus B19 infection-related complications in renal transplant recipients: Treatment with intravenous immunoglobulin. Transplantation 64: 1847-1850, 1997
41. Barsoum NR, Bunnapradist S, Mougdil A, Toyoda M, Vo A, Jordan SC: Treatment of parvovirus B-19 (PV B-19) infection allows for successful kidney transplantation without disease recurrence. Am J Transplant 2: 425-428, 2002
42. Coventry S, Shoemaker LR: Collapsing glomerulopathy in a 16-year-old girl with pulmonary tuberculosis: The role of systemic inflammatory mediators. Pediatr Dev Pathol 7: 166-170, 2004
43. Leblond V, Beaufils H, Ginsburg C, Bricaire F, Danis M, Deray G, Jacobs C: Collapsing focal segmental glomerulosclerosis associated with visceral leishmaniasis. Nephrol Dial Transplant 9: 1353, 1994
44. Wiederkehr MR, Rogers TE, Moe OW: Collapsing glomerulopathy: A cause of noncardiogenic pulmonary edema. Am J Kidney Dis 40: E10, 2002
45. Hamad A, Balsam L: Fulminant acute nephrotic syndrome in a patient with idiopathic collapsing focal segmental glomerulosclerosis after a febrile illness. Am J Nephrol 21: 84-85, 2001
46. Shimamura T, Walker J: A collapsing form of glomerulopathy. Pathol Int 45: 520-523, 1995
47. Kumar S, Sheaff M, Yaqoob M: Collapsing glomerulopathy in adult Still's disease. Am J Kidney Dis 43: e4-e10, 2004
48. Bennett AN, Peterson P, Sangle S, Hangartner R, Abbs IC, Hughes GR, D'Cruz DP: Adult onset Still's disease and collapsing glomerulopathy: Successful treatment with intravenous immunoglobulins and mycophenolate mofetil. Rheumatology 43: 795-799, 2004
49. Amoura Z, Georgin-Lavialle S, Haroche J, Merrien D, Brocheriou I, Beaufils H, Piette JC: Collapsing glomerulopathy in systemic autoimmune disorders: A case occurring in the course of full blown systemic lupus erythematosus. Ann Rheum Dis 65: 277-278, 2006
50. Marques LP, Pacheco GG, Rioja LS, Nunes SN, Velone ST, Santos OR: Can systemic lupus erythematosus be the cause of collapsing glomerulopathy? Lupus 14: 853-855, 2005
51. Arbel O, Pizov G, Ben-Yehuda A, Rubinow A, Naparstek Y, Amital H: Hyperacute renal failure as the initial presentation of systemic lupus erythematosus. Lupus 14: 331-333, 2005
52. Shah S, Cavenagh J, Sheaf M, Thuraisingham RC: Remission of collapsing focal segmental glomerulosclerosis following chemotherapy for myeloma. Am J Kidney Dis 43: e10-e12, 2004
53. Bhowmik D, Dinda AK, Gupta S, Agarwal SK, Tiwari SC, Dash SC: Multiple myeloma presenting as collapsing glomerulopathy. Indian J Pathol Microbiol 46: 233-234, 2003
54. Thaunat O, Delahousse M, Fakhouri F, Martinez F, Stephan JL, Noel LH, Karras A: Nephrotic syndrome associated with hemophagocytic syndrome. Kidney Int 69: 1892-1898, 2006
55. Badhwar A, Berkovic SF, Dowling JP, Gonzales M, Narayanan S, Brodtmann A, Berzen L, Caviness J, Trenkwalder C, Winkelmann J, Rivest J, Lambert M, Hernandez-Cossio O, Carpenter S, Andermann F, Andermann E: Action myoclonus-renal failure syndrome: Characterization of a unique cerebro-renal disorder. Brain 127: 2173-2182, 2004
56. Scaglia F, Vogel H, Hawkins EP, Vladutiu GD, Liu LL, Wong LJ: Novel homoplasmic mutation in the mitochondrial tRNATyr gene associated with atypical mitochondrial cytopathy presenting with focal segmental glomerulosclerosis. Am J Med Genet A 123: 172-178, 2003
57. Avila-Casado MC, Vargas-Alarcon G, Soto ME, Hernandez G, Reyes PA, Herrera-Acosta J: Familial collapsing glomerulopathy: Clinical, pathological and immunogenetic features. Kidney Int 63: 233-239, 2003
58. Nasr SH, Markowitz GS, Sentman RL, D'Agati VD: Sickle cell disease, nephritic syndrome, and renal failure. Kidney Int 69: 1276-1280, 2006
59. Stein DF, Ahmed A, Sunkhara V, Khalbuss W: Collapsing focal segmental glomerulosclerosis with recovery of renal function: An uncommon complication of interferon therapy for hepatitis C. Dig Dis Sci 46: 530-535, 2001
60. Barri YM, Munshi NC, Sukumalchantra S, Abulezz SR, Bonsib SM, Wallach J, Walker PD: Podocyte injury associated glomerulopathies induced by pamidronate. Kidney Int 65: 634-641, 2004
61. Kunin M, Kopolovic J, Avigdor A, Holtzman EJ: Collapsing glomerulopathy induced by long-term treatment with standard-dose pamidronate in a myeloma patient. Nephrol Dial Transplant 19: 723-726, 2004
62. Loi S, Perry GJ, Standish H, Dowling J: Glomerulosclerosis: A paraneoplastic phenomenon? Nephrology 9: 387-391, 2004
63. Markowitz GS, Appel GB, Fine PL, Fenves AZ, Loon NR, Jagannath S, Kuhn JA, Dratch AD, D'Agati VD: Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol 12: 1164-1172, 2001
64. Foster S, Hawkins E, Hanson CG, Shearer W: Pathology of the kidney in childhood immunodeficiency: AIDS-related nephropathy is not unique. Pediatr Pathol 11: 63-74, 1991
65. Meehan SM, Pascual M, Williams WW, Tolkoff-Rubin N, Delmonico FL, Cosimi AB, Colvin RB: De novo collapsing glomerulopathy in renal allografts. Transplantation 65: 1192-1197, 1998
66. Stokes MB, Davis CL, Alpers CE: Collapsing glomerulopathy in renal allografts: A morphological pattern with diverse clinicopathologic associations. Am J Kidney Dis 33: 658-666, 1999
67. Korbet SM, Schwartz MM, Lewis EJ: Recurrent nephrotic syndrome in renal allografts. Am J Kidney Dis 11: 270-276, 1988
68. Clarkson MR, O'Meara YM, Murphy B, Rennke HG, Brady HR: Collapsing glomerulopathy: Recurrence in a renal allograft. Nephrol Dial Transplant 13: 503-506, 1998
69. Toth CM, Pascual M, Williams WW Jr, Delmonico FL, Cosimi AB, Colvin RB, Tolkoff-Rubin N: Recurrent collapsing glomerulopathy. Transplantation 65: 1009-1010, 1998
70. Nadasdy T, Allen C, Zand MS: Zonal distribution of glomerular collapse in renal allografts: Possible role of vascular changes. Hum Pathol 33: 437-441, 2002
71. Tipping PG, Kitching AR: Glomerulonephritis, Th1 and Th2: What's new? Clin Exp Immunol 142: 207-215, 2005
72. Tipping PG, Holdsworth SR: T cells in crescentic glomerulonephritis. J Am Soc Nephrol 17: 1253-1263, 2006
73. Barisoni L, Madaio MP, Eraso M, Gasser DL, Nelson PJ: The kd/kd mouse is a model of collapsing glomerulopathy. J Am Soc Nephrol 16: 2847-2851, 2005
74. Bouchier-Hayes L, Lartigue L, Newmeyer DD: Mitochondria: Pharmacological manipulation of cell death. J Clin Invest 115: 2640-2647, 2005
75. Dickie P, Felser J, Eckhaus M, Bryant J, Silver J, Marinos N, Notkins AL: HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185: 109-119, 1991
76. Hanna Z, Kay DG, Cool M, Jothy S, Rebai N, Jolicoeur P: Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease. J Virol 72: 121-132, 1998
77. Hu C, Vincent P, Kay DG, Simard M, Hanna Z, Jolicoeur P: HIV Nef-induced collapsing glomerulopathy in CD4C/HIV Tg mice [Abstract]. J Am Soc Nephrol 16: 652A, 2005
78. Ray PE, Liu XH, Robinson LR, Reid W, Xu L, Owens JW, Jones OD, Denaro F, Davis HG, Bryant JL: A novel HIV-1 transgenic rat model of childhood HIV-1-associated nephropathy. Kidney Int 63: 2242-2253, 2003
79. Dickie P, Roberts A, Uwiera R, Witmer J, Sharma K, Kopp JB: Focal glomerulosclerosis in proviral and c-fms transgenic mice links Vpr expression to HIV-associated nephropathy. Virology 322: 69-81, 2004
80. Zhong J, Zuo Y, Ma J, Fogo AB, Jolicoeur P, Ichikawa I, Matsusaka T: Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int 68: 1048-1060, 2005
81. Kim YG, Alpers CE, Brugarolas J, Johnson RJ, Couser WG, Shankland SJ: The cyclin kinase inhibitor p21CIP1/WAF1 limits glomerular epithelial cell proliferation in experimental glomerulonephritis. Kidney Int 55: 2349-2361, 1999
82. Smeets B, Te Loeke NA, Dijkman HB, Steenbergen ML, Lensen JF, Begieneman MP, van Kuppevelt TH, Wetzels JF, Steenbergen EJ: The parietal epithelial cell: A key player in the pathogenesis of focal segmental glomerulosclerosis in Thy-1.1 transgenic mice. J Am Soc Nephrol 15: 928-939, 2004
83. Matsusaka T, Xin J, Niwa S, Kobayashi K, Akatsuka A, Hashizume H, Wang QC, Pastan I, Fogo AB, Ichikawa I: Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. J Am Soc Nephrol 16: 1013-1023, 2005
84. Kimura T, Takeda S, Sagiya Y, Gotoh M, Nakamura Y, Arakawa H: Impaired function of p53R2 in Rrm2b-null mice causes severe renal failure through attenuation of dNTP pools. Nat Genet 34: 440-445, 2003
85. Powell DR, Desai U, Sparks MJ, Hansen G, Gay J, Schrick J, Shi ZZ, Hicks J, Vogel P: Rapid development of glomerular injury and renal failure in mice lacking p53R2. Pediatr Nephrol 20: 432-440, 2005
86. Hermann M, Shaw S, Kiss E, Camici G, Buhler N, Chenevard R, Luscher TF, Grone HJ, Ruschitzka F: Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension. Hypertension 45: 193-197, 2005
87. Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, Gerber HP, Kikkawa Y, Miner JH, Quaggin SE: Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111: 707-716, 2003
88. Dickie P: Nef modulation of HIV type 1 gene expression and cytopathicity in tissues of HIV transgenic mice. AIDS Res Hum Retroviruses 16: 777-790, 2000
89. Kopp JB, Klotman ME, Adler SH, Bruggeman LA, Dickie P, Marinos NJ, Eckhaus M, Bryant JL, Notkins AL, Klotman PE: Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci U S A 89: 1577-1581, 1992
90. Shirai A, Klinman DM: Immunization with recombinant gp160 prolongs the survival of HIV-1 transgenic mice. AIDS Res Hum Retroviruses 9: 979-983, 1993
91. Ray PE, Bruggeman LA, Weeks BS, Kopp JB, Bryant JL, Owens JW, Notkins AL, Klotman PE: bFGF and its low affinity receptors in the pathogenesis of HIV-associated nephropathy in transgenic mice. Kidney Int 46: 759-772, 1994
92. Tang P, Jerebtsova M, Przygodzki R, Ray PE: Fibroblast growth factor-2 increases the renal recruitment and attachment of HIV-infected mononuclear cells to renal tubular epithelial cells. Pediatr Nephrol 20: 1708-1716, 2005
93. Bruggeman LA, Thomson MM, Nelson PJ, Kopp JB, Rappaport J, Klotman PE, Klotman ME: Patterns of HIV-1 mRNA expression in transgenic mice are tissue-dependent. Virology 202: 940-948, 1994
94. Bruggeman LA, Dikman S, Meng C, Quaggin SE, Coffman TM, Klotman PE: Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 100: 84-92, 1997
95. Barisoni L, Bruggeman LA, Mundel P, D'Agati VD, Klotman PE: HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney Int 58: 173-181, 2000
96. Bruggeman LA, Adler SH, Klotman PE: Nuclear factor-kappa B binding to the HIV-1 LTR in kidney: Implications for HIV-associated nephropathy. Kidney Int 59: 2174-2181, 2001
97. Shrivastav S, Cusumano A, Kanno Y, Chen G, Bryant JL, Kopp JB: Role of T lymphocytes in renal disease in HIV-transgenic mice. Am J Kidney Dis 35: 408-417, 2000
98. Kajiyama W, Kopp JB, Marinos NJ, Klotman PE, Dickie P: Glomerulosclerosis and viral gene expression in HIV-transgenic mice: Role of nef. Kidney Int 58: 1148-1159, 2000
99. Singhal PC, Sharma P, Loona R, Gibbons N, Franki N, Klotman PE: Enhanced proliferation, apoptosis, and matrix accumulation by mesangial cells derived from HIV-1 transgenic mice. J Investig Med 46: 297-302, 1998
100. Ross MJ, Martinka S, D'Agati VD, Bruggeman LA: NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy. J Am Soc Nephrol 16: 2403-2411, 2005
101. Gharavi AG, Ahmad T, Wong RD, Hooshyar R, Vaughn J, Oller S, Frankel RZ, Bruggeman LA, D'Agati VD, Klotman PE, Lifton RP: Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. Proc Natl Acad Sci U S A 101: 2488-2493, 2004
102. Vincent P, Priceputu E, Kay D, Saksela K, Jolicoeur P, Hanna Z: Activation of p21-activated kinase 2 and its association with Nef are conserved in murine cells but are not sufficient to induce an AIDS-like disease in CD4C/HIV transgenic mice. J Biol Chem 281: 6940-6954, 2005
103. Priceputu E, Rodrigue I, Chrobak P, Poudrier J, Mak TW, Hanna Z, Hu C, Kay DG, Jolicoeur P: The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice. J Virol 79: 6377-6391, 2005
104. Hanna Z, Kay DG, Rebai N, Guimond A, Jothy S, Jolicoeur P: Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95: 163-175, 1998
105. Hanna Z, Weng X, Kay DG, Poudrier J, Lowell C, Jolicoeur P: The pathogenicity of human immunodeficiency virus (HIV) type 1 nef in CD4C/HIV transgenic mice is abolished by mutation of its sh3-binding domain, and disease development is delayed in the absence of hck. J Virol 75: 9378-9392, 2001
106. Hanna Z, Priceputu E, Kay DG, Poudrier J, Chrobak P, Jolicoeur P: In vivo mutational analysis of the N-terminal region of HIV-1 Nef reveals critical motifs for the development of an AIDS-like disease in CD4C/HIV transgenic mice. Virology 327: 273-286, 2004
107. Husain M, D'Agati VD, He JC, Klotman ME, Klotman PE: HIV-1 Nef induces dedifferentiation of podocytes in vivo: A characteristic feature of HIVAN. AIDS 19: 1975-1980, 2005
108. Soos TJ, Sims TN, Barisoni L, Lin K, Littman DR, Dustin ML, Nelson PJ: CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int 70: 591-596, 2006
109. Larsson M: HIV-1 and the hijacking of dendritic cells: A tug of war. Springer Semin Immun 26: 309-328, 2005
110. Avila-Casado Mdel C, Perez-Torres I, Auron A, Soto V, Fortoul TI, Herrera-Acosta J: Proteinuria in rats induced by serum from patients with collapsing glomerulopathy. Kidney Int 66: 133-143, 2004
111. Hallman TM, Peng M, Meade R, Hancock WW, Madaio MP, Gasser DL: The mitochondrial and kidney disease phenotypes of kd/kd mice under germfree conditions. J Autoimmun 26: 1-6, 2006
112. Foster RR, Hole R, Anderson K, Satchell SC, Coward RJ, Mathieson PW, Gillatt DA, Saleem MA, Bates DO, Harper SJ: Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. Am J Physiol Renal Physiol 284: F1263-F1273, 2003
113. Foster RR, Saleem MA, Mathieson PW, Bates DO, Harper SJ: Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes. Am J Physiol Renal Physiol 288: F48-F57, 2005
114. Eremina V, Quaggin SE: The role of VEGF-A in glomerular development and function. Curr Opin Nephrol Hypertens 13: 9-15, 2004
115. Ballermann BJ: Glomerular endothelial cell differentiation. Kidney Int 67: 1668-1671, 2005
116. Clevers H: At the crossroads of inflammation and cancer. Cell 118: 671-674, 2004
117. Karin M, Greten FR: NF-kappaB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-759, 2005
118. Hancock WW, Tsai TL, Madaio MP, Gasser DL: Cutting edge: Multiple autoimmune pathways in kd/kd mice. J Immunol 171: 2778-2781, 2003
119. Schwimmer JA, Markowitz GS, Valeri A, Appel GB: Collapsing glomerulopathy. Semin Nephrol 23: 209-218, 2003
120. Chun MJ, Korbet SM, Schwartz MM, Lewis EJ: Focal segmental glomerulosclerosis in nephrotic adults: Presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol 15: 2169-2177, 2004
121. Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA, Tashima KT, Roland M, Franceschini N, Palella FJ, Lennox JL, Klotman PE, Nachman SA, Hall SD, Szczech LA: Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 40: 1559-1585, 2005
122. Singh HK, Baldree LA, McKenney DW, Hogan SL, Jennette JC: Idiopathic collapsing glomerulopathy in children. Pediatr Nephrol 14: 132-137, 2000
123. Schwartz EJ, Szczech LA, Ross MJ, Klotman ME, Winston JA, Klotman PE: Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol 16: 2412-2420, 2005
124. Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, Appel R, Fields TA, Svetkey LP, Flanagan KH, Klotman PE, Winston JA: The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 66: 1145-1152, 2004
125. Nelson PJ, Shankland SJ: Therapeutics in renal disease: The road ahead for antiproliferative targets. Nephron Exp Nephrol 103: e6-e15, 2006
126. Nelson PJ, D'Agati VD, Gries JM, Suarez JR, Gelman IH: Amelioration of nephropathy in mice expressing HIV-1 genes by the cyclin-dependent kinase inhibitor flavopiridol. J Antimicrob Chemother 51: 921-929, 2003
127. Gherardi D, D'Agati V, Chu TH, Barnett A, Gianella-Borradori A, Gelman IH, Nelson PJ: Reversal of collapsing glomerulopathy in mice with the cyclin-dependent kinase inhibitor CYC202. J Am Soc Nephrol 15: 1212-1222, 2004
128. Griffin SV, Krofft RD, Pippin JW, Shankland SJ: Limitation of podocyte proliferation improves renal function in experimental crescentic glomerulonephritis. Kidney Int 67: 977-986, 2005
129. Soos TJ, Meijer L, Nelson PJ: CDK/GSK-3 inhibitors as a new approach for the treatment of proliferative renal diseases. Drug News Perspect 19: 314-317, 2006
130. Vaughan MR, Pippin JW, Griffin SV, Krofft R, Fleet M, Haseley L, Shankland SJ: ATRA induces podocyte differentiation and alters nephrin and podocin expression in vitro and in vivo. Kidney Int 68: 133-144, 2005
131. Heckmann A, Waltzinger C, Jolicoeur P, Dreano M, Kosco-Vilbois MH, Sagot Y: IKK2 inhibitor alleviates kidney and wasting diseases in a murine model of human AIDS. Am J Pathol 164: 1253-1262, 2004
132. Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D'Agati VD: C1q nephropathy: A variant of focal segmental glomerulosclerosis. Kidney Int 64: 1232-1240, 2003